Johnson & Johnson

NYSE: JNJ · Real-Time Price · USD
179.49
0.65 (0.36%)
At close: Aug 21, 2025, 11:54 AM

Johnson & Johnson Cash Flow Statement

Financials in USD. Fiscal year is February - January.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 29, 2025 Mar 30, 2025 Dec 29, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Jan 1, 2023 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Jan 2, 2022 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Net Income
22.66B 21.81B 14.07B 14.77B 16.38B 16.84B 13.52B 12.9B 13.05B 12.72B 17.94B 19.16B 18.37B 19.83B 20.88B 17.88B 17.77B 15.12B
Depreciation & Amortization
7.46B 7.3B 7.34B 7.29B 7.27B 7.42B 7.49B 7.42B 7.27B 7.08B 6.97B 7.04B 7.17B 7.26B 7.39B 7.49B 7.49B 7.38B
Stock-Based Compensation
1.23B 1.16B 1.18B 1.12B 1.12B 1.16B 1.16B 1.2B 1.18B 1.17B 1.14B 1.14B 1.12B 1.11B 1.14B 1.08B 1.08B 1.05B
Other Working Capital
-11.03B -8.85B 1.75B 1.84B 508M -533M 2.11B -953M -100M 3.02B -1.29B -359M 15.48B 30.57B 31.08B 40.74B 44.14B 38.22B
Other Non-Cash Items
1.93B 1.81B 2.03B 2.27B 2.13B 2.08B 2.31B 1.7B 629M 790M 819M 581M 1.48B 1.35B 324M 276M -697M -592M
Deferred Income Tax
3.07B 1.55B -2.18B -4.58B -4.11B -4.21B -4.19B -957M -1.66B -2.28B -1.66B -2B -3.74B -2.27B -2.08B -3.47B -1.4B -1.93B
Change in Working Capital
-13.32B -8.85B 1.84B 4.29B 1.85B -94M 2.51B -1.98B -1.41B 991M -4.01B -4.34B -811M -3.96B -4.24B 2.77B 1.87B 3.23B
Operating Cash Flow
23.03B 24.78B 24.27B 25.15B 24.64B 23.19B 22.79B 20.28B 19.07B 20.47B 21.19B 21.58B 23.58B 23.32B 23.41B 26.02B 26.11B 24.25B
Capital Expenditures
-6.63B -6.21B -6.21B -5.65B -4.34B -4.49B -4.54B -4.54B -4.53B -4.26B -4.01B -3.84B -3.63B -3.58B -3.65B -3.56B -3.55B -3.4B
Cash Acquisitions
-14.8B -12.97B -14.57B -14.45B -13.99B -1.28B 358M -16.89B -17.01B -17.36B -17.65B -582M -571M -300M -48M -6.36B -6.37B -6.38B
Purchase of Investments
-3.66B -1.35B -1.73B -2.39B -2.4B -7.76B -10.91B -11.2B -20.01B -27.14B -32.38B -42.71B -40.19B -33.42B -30.39B -23.69B -24.8B -25.02B
Sales Maturities Of Investments
1.71B 1.7B 2.46B 5.78B 9.22B 12.6B 19.39B 31.07B 35.85B 43.07B 41.61B 34.52B 30.19B 26.52B 25.45B 22.68B 21.94B 14.08B
Other Investing Acitivies
-978M -595M 469M -2.21B -1.3B -1.97B -3.42B -753M -858M 271M 65M -722M -136M -1.34B -24M -280M -542M 290M
Investing Cash Flow
-23.01B -18.43B -18.6B -18.48B -12.81B -2.9B 878M -2.32B -6.56B -5.42B -12.37B -13.33B -14.35B -12.13B -8.68B -11.23B -13.33B -20.43B
Debt Repayment
6.81B 20.73B 10.05B 7.42B 7.4B -11.24B -2.73B 5.66B 13.2B 20.3B 7.45B 156M 691M 493M -990M -3.79B 2.76B 5.66B
Common Stock Repurchased
-2.95B -3.08B -2.43B -2.37B -2.75B -2.99B -5.05B -6.16B -7.4B -8B -6.04B -5.71B -3.94B -3.6B -3.46B -2.78B -2.87B -2.95B
Dividend Paid
-12.09B -11.94B -11.82B -11.7B -11.59B -11.7B -11.77B -11.86B -11.96B -11.84B -11.68B -11.52B -11.34B -11.16B -11.03B -10.9B -10.77B -10.63B
Other Financial Acitivies
1.76B 1.04B 1.07B 203M -945M 4.51B 3.73B 2.89B 4.09B 1.18B 1.39B 3.07B 2.3B 955M 1.2B 975M 788M 755M
Financial Cash Flow
-6.46B 6.74B -3.13B -6.45B -7.88B -21.42B -15.82B -9.47B -2.08B 1.65B -8.87B -14.01B -12.29B -13.31B -14.05B -16.25B -9.85B -6.93B
Net Cash Flow
-6.3B 13B 2.25B 252M 3.69B -1.39B 7.73B 8.37B 10.2B 16.4B -360M -6.25B -3.35B -2.21B 502M -1.36B 3.16B -2.86B
Free Cash Flow
16.4B 18.57B 18.06B 19.5B 20.3B 18.7B 18.25B 15.74B 14.55B 16.21B 17.18B 17.74B 19.95B 19.73B 19.76B 22.46B 22.56B 20.85B